InfoSearched
Published - 02/03/2020 8:35 pm
7-year-old Maverick has a rare genetic disorder that severely limits his vision. Now, a medication called Luxturna – the first gene therapy approved by the FDA – has the potential to substantially improve his sight, via an injection of a gene-carrying virus underneath his retina.
Feel free to help out the website by checking out this item on Amazon. There’s a small commission we earn if you decide to purchase anything through the link below. Thanks.
GUIDE TO HUMAN GENE THERAPY:
